Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy

R D Leachman1

  • 1Department of Adult Cardiology, Texas Heart Institute, Houston 77030, USA.

Insights

Treatments for hypertrophic obstructive cardiomyopathy focus on improving systolic and diastolic dysfunction. Interventions include surgical procedures, pacemakers, and medications to manage arrhythmias and optimize heart rate.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) presents with complex ventricular dysfunction.
  • Associated conditions include mitral valve regurgitation, arrhythmias, and coronary atherosclerosis.

Purpose of the Study:

  • To summarize the abnormalities, causes, and treatments of hypertrophic obstructive cardiomyopathy.
  • To outline therapeutic strategies for systolic and diastolic ventricular dysfunction in HOCM.

Main Methods:

  • Review of treatment modalities for HOCM.
  • Discussion of pharmacological and interventional approaches.

Main Results:

  • Systolic dysfunction due to left ventricular outlet obstruction can be improved by myotomy, myomectomy, or mitral valve replacement.
  • Diastolic dysfunction may benefit from optimized filling periods, shortened relaxation times (e.g., calcium channel blockers), or adjusted atrioventricular pacing.
  • Arrhythmias are managed with medications like beta-blockers or antiarrhythmic agents.
  • Coronary atherosclerosis may require surgical bypass.
  • Optimal heart rate management is crucial as cardiac output is rate-dependent.

Conclusions:

  • A multifaceted treatment approach is necessary for HOCM, addressing both ventricular dysfunction and associated complications.
  • Individualized medication dosages are essential for achieving optimal heart rate and physiological state.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...